全文获取类型
收费全文 | 4095篇 |
免费 | 165篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 423篇 |
妇产科学 | 122篇 |
基础医学 | 444篇 |
口腔科学 | 88篇 |
临床医学 | 268篇 |
内科学 | 933篇 |
皮肤病学 | 54篇 |
神经病学 | 240篇 |
特种医学 | 181篇 |
外科学 | 528篇 |
综合类 | 78篇 |
一般理论 | 3篇 |
预防医学 | 197篇 |
眼科学 | 185篇 |
药学 | 225篇 |
中国医学 | 16篇 |
肿瘤学 | 257篇 |
出版年
2023年 | 25篇 |
2022年 | 42篇 |
2021年 | 114篇 |
2020年 | 79篇 |
2019年 | 101篇 |
2018年 | 134篇 |
2017年 | 76篇 |
2016年 | 95篇 |
2015年 | 98篇 |
2014年 | 161篇 |
2013年 | 210篇 |
2012年 | 315篇 |
2011年 | 384篇 |
2010年 | 195篇 |
2009年 | 137篇 |
2008年 | 230篇 |
2007年 | 258篇 |
2006年 | 219篇 |
2005年 | 207篇 |
2004年 | 183篇 |
2003年 | 162篇 |
2002年 | 168篇 |
2001年 | 62篇 |
2000年 | 52篇 |
1999年 | 41篇 |
1998年 | 29篇 |
1997年 | 19篇 |
1996年 | 14篇 |
1995年 | 9篇 |
1994年 | 18篇 |
1993年 | 15篇 |
1992年 | 41篇 |
1991年 | 30篇 |
1990年 | 31篇 |
1989年 | 26篇 |
1988年 | 35篇 |
1987年 | 27篇 |
1986年 | 19篇 |
1985年 | 34篇 |
1984年 | 21篇 |
1983年 | 20篇 |
1980年 | 7篇 |
1979年 | 16篇 |
1978年 | 10篇 |
1977年 | 16篇 |
1975年 | 13篇 |
1973年 | 10篇 |
1972年 | 9篇 |
1970年 | 7篇 |
1967年 | 7篇 |
排序方式: 共有4271条查询结果,搜索用时 125 毫秒
91.
92.
Guntram Schernthaner MD Per-Henrik Groop MD Philip A. Kalra MD Claudio Ronco MD Maarten W. Taal MD 《Diabetes, obesity & metabolism》2020,22(7):1024-1034
Data from three completed cardiovascular outcome trials (CVOTs), EMPA-REG OUTCOME, CANVAS Program and DECLARE-TIMI 58, add to the evidence supporting the potential renoprotective effects of sodium-glucose linked transporter-2 (SGLT2) inhibitors in patients with type 2 diabetes. Despite recommendations in recent guidelines, it is difficult to support a view that definitive evidence for renoprotection exists from these SGLT2 inhibitor CVOT results. To date, the only dedicated trial to report definitive data on the renal impact of SGLT2 inhibition is CREDENCE. Notably, the total number of patient-relevant renal endpoint events (dialysis, transplant or renal death) observed in CREDENCE was significantly higher than the total for all three CVOTs collectively (183 events/4401 patients vs. 69 events/34 322 patients, respectively), which shows the increased statistical power of CREDENCE for these renal endpoints. Treatment with canagliflozin was associated with a 30% relative risk reduction (RRR) in the primary composite endpoint of end-stage kidney disease, doubling of serum creatinine, or death from renal or cardiovascular causes and a 34% RRR for the renal-specific elements of this primary endpoint (P <0.001). Canagliflozin has therefore become the first US-approved SGLT2 inhibitor to include an indication for RRR, in addition to type 2 diabetes glycaemic control and cardiovascular risk reduction. While confirmatory of the exploratory data from CVOTs, CREDENCE provides the first robust data on the effects of canagliflozin on patient-relevant renal endpoints. Extrapolation to a conclusion of a SGLT2 inhibitor class effect cannot be made until additional renal trials with other SGLT2 inhibitors are reported. 相似文献
93.
94.
95.
Gloviczki P Kalra M Duncan AA Oderich GS Vrtiska TJ Bower TC 《Phlebology / Venous Forum of the Royal Society of Medicine》2012,27(Z1):103-106
Endovascular reconstruction has become the standard treatment of chronic obstruction of large veins. Stenting is done with increasing frequency to treat iliac venous obstructions, with or without associated inferior vena caval or femoral vein occlusions. Open reconstruction with venous bypass is performed today in patients who fail attempts at venous stenting or who are not candidates for endovascular reconstructions. Patients with primary or secondary malignancies invading the vena cava undergo open caval reconstruction at the time of tumour excision. Open venous reconstructions are still preferred in patients with large vein injuries due to blunt or penetrating trauma or in those who suffer iatrogenic venous injuries. Hybrid reconstruction can be performed with endophlebectomy of the common femoral or femoral veins combined with iliofemoral stenting. 相似文献
96.
Stephan von Haehling Joerg C. Schefold Ewa A. Jankowska Jochen Springer Ali Vazir Paul R. Kalra Anja Sandek Günter Fauler Tatjana Stojakovic Michael Trauner Piotr Ponikowski Hans-Dieter Volk Wolfram Doehner Andrew J.S. Coats Philip A. Poole-Wilson Stefan D. Anker 《Journal of the American College of Cardiology》2012
97.
98.
99.
Background. There is sparse literature on the association of adipose tissue with liver histology in patients with nonalcoholic fatty liver disease (NAFLD).Aim. To study the correlation of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT) and total adipose tissue (TAT) with liver histology in Indian patients with NAFLD.Material and methods. A single slice CT scan at the level of L4-L5 vertebrae was done to assess the abdominal VAT and SAT volumes in 21 patients with histological diagnosis of NAFLD. Adult treatment panel III criteria with modified abnormal waist were used to define metabolic syndrome (MS). Histological grading was done according to the NAFLD activity score (NAS).Results. Twenty-one patients with NAFLD [13 males, median age: 35 years, median BMI: 25.97 kg/m2] were included prospectively. Even though overweight/obese patients had severe liver disease, there was no difference in the volume of VAT adjusted for BMI between 6 (28.5%) lean and 15 (71.5%) overweight/obese patients. Patients with NASH and borderline NASH were older, obese with higher VAT and SAT volumes than no-NASH group. SAT volume (SATV) correlated significantly with hepatic steatosis but none of the adipose tissue volumes had any correlation with other histological variables. Both SATV and TAT volume (TATV) correlated significantly with severity of liver disease as determined by NAS score whereas presence of MS or insulin resistance had no correlation with histological severity.Conclusion. Both subcutaneous and total adipose tissue volume are related to the disease severity as determined by NAFLD activity score in Indian patients with NAFLD. 相似文献
100.
A simple synthetic strategy has been developed for the synthesis of 2- and 1-alkyl/aryl/dialkylaminoquinolines and isoquinolines from the easily available quinoline and isoquinoline-N-oxides, different amines, triflic anhydride as activating agent and acetonitrile as solvent in a one-pot reaction under metal-free conditions at 0 °C to room temperature.A synthetic strategy has been developed for synthesis of 2 and 1-aminoquinolines and isoquinolines from quinoline and isoquinoline-N-oxides, amines and triflic anhydride in acetonitrile at 0 °C to room temperature. 相似文献